|
| | PantoprazoleSodiumSesquihydrate Basic information |
| Product Name: | PantoprazoleSodiumSesquihydrate | | Synonyms: | Pantoprazole sodium hydrate;1H-Benzimidazole, 5-(difluoromethoxy)-2-(((3,4-dimethoxy-2-pyridinyl)methyl)sulfinyl)-, sodium salt, hydrate (2:3);Unii-6871619Q5x;6-(Difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole sodium salt hydrate (2:2:3);SKF-96022 SODIUM HYDRATE;Pantoprazole sodium sesquihydrate CRS;Pantoprazole for system suitability CRS;BY1023 (sodium hydrate) | | CAS: | 164579-32-2 | | MF: | C16H18F2N3NaO5S | | MW: | 425.38 | | EINECS: | 1312995-182-4 | | Product Categories: | | | Mol File: | 164579-32-2.mol |  |
| | PantoprazoleSodiumSesquihydrate Chemical Properties |
| storage temp. | 4°C, protect from light | | solubility | Freely soluble in water and in ethanol (96 per cent), practically insoluble in hexane. | | form | neat |
| Hazard Codes | Xn | | Risk Statements | 22 | | WGK Germany | nwg | | HS Code | 2933399090 |
| | PantoprazoleSodiumSesquihydrate Usage And Synthesis |
| Chemical Properties | White or almost white powder. | | Uses | Pantoprazole Sodium Hydrate is a metabolite of Pantoprazole Sodium Salt which is an antiulcerative. Gastric pump inhibitor. The free acid, Pantoprazole is a prodrug used in the treatment of acid related disorders and Helicobacter pylori infections. | | Uses | Treatment of various acid-related gastrointestinal diseases, including acute erosive esophagitishealing and maintenance, treatment of hypersecretory
conditions, Zollinger-Ellison Syndrome (ZES), and eradication
of Helicobacter pylori infection. | | Brand name | Protonix (Wyeth). |
| | PantoprazoleSodiumSesquihydrate Preparation Products And Raw materials |
|
